Organcia, Luzmarie S.
HRN: 26-33-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/11/2025
03/17/2025
IVTT
2.25 G
Q6
Complicated Urinary Tract Infection
Waiting Final Action
Indication: Culture-directed Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes